Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Multiple Myeloma 74Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Burkitt Lymphoma 25Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11Recurrence 8Immunoglobulin Light-chain Amyloidosis 8Vomiting 7Nausea 7Lymphoma, Mantle-Cell 7Leukemia, Biphenotypic, Acute 7Lymphoma, Large B-Cell, Diffuse 6Lymphoma 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 5Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 5Leukemia 5Hodgkin Disease 5Smoldering Multiple Myeloma 4Neoplasms, Plasma Cell 4Neoplasm Metastasis 4Breast Neoplasms 4Blast Crisis 4Prostatic Neoplasms 3Plasmacytoma 3Ovarian Neoplasms 3Myelodysplastic Syndromes 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Lung Neoplasms 3

Interventions

Docetaxel 292Prednisone 240enzalutamide 193Leuprolide 185Radiotherapy 179Abiraterone Acetate 169Magnetic Resonance Spectroscopy 163bicalutamide 141Goserelin 138Androgen Antagonists 121acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 108Radiosurgery 108apalutamide 92gallium 68 PSMA-11 81abiraterone 81Specimen Handling 73darolutamide 65Surveys and Questionnaires 64Gonadotropin-Releasing Hormone 63Triptorelin Pamoate 58Radiation 57Biopsy 57Brachytherapy 54cabazitaxel 52Standard of Care 51Radiotherapy, Intensity-Modulated 51Zoledronic Acid 50pembrolizumab 49luprolide acetate gel depot 49Flutamide 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Prostatic Neoplasms × dexamethasone acetate × Clear all
NCT06136598 2026-03-19

MK-5684-001

Merck Sharp & Dohme LLC

Phase 1 Completed
14 enrolled
Genitourinary

Prostatic Neoplasms

NCT02491411 2018-07-12

DEXTER

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Terminated
5 enrolled 5 charts
Genitourinary

Prostatic Neoplasms

NCT00427999 2016-11-21

INV342

Novartis

Phase 2 Completed
67 enrolled 6 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡